- Investopedia•3 hours ago
The approval of a single-tablet, three-drug combo could boost Gilead's bottom line.
- 24/7 Wall St.•22 hours ago
December 8, 2016: Here are four stocks trading with relatively heavy volume among 34 equities making new 52-week lows in Thursday’s session. On the NYSE, advancers led decliners by about 3 to 2 and on ...
BMO's M. Ian Somaiya and team contend that while Gilead Sciences' (GILD) hepatitis-c sales will remain under pressure, its HIV business should make up for it: We sat down with Gilead management during ...
GILD : Summary for Gilead Sciences, Inc. - Yahoo Finance
Gilead Sciences Inc. (GILD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||72.86 x 300|
|Ask||72.87 x 300|
|Day's Range||71.95 - 73.13|
|52 Week Range||70.83 - 104.79|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||6.73|
|Dividend & Yield||1.88 (2.60%)|
|1y Target Est||N/A|